Welcome : Guest

Achaogen, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Achaogen, Inc., which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 17 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-63637
Price: $850
Company Type: Public
Pages: 19
Date: November 2016
Market Data Tables: 17

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Antibacterials......3
Table 1: Prescription Therapeutic Market by Segment in the US (2015) - Percentage Market Share Breakdown by Volume Sales for Antibacterials, Antidiateics, Antihypertensives, Lipid Regulators, Mental Health, CNS, Pain, Respiratory Agents, and Others......3
Table 2: Branded Acute Bacterial Skin and Skin Structure Infection Antibiotic Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Cubicin (Daptomycin), Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......4
Table 3: Branded Community-Acquired Bacterial Pneumonia Antibiotic Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......5
Table 4: High Risk Patients Diagnosed With Sepsis by Type in the US (2015) - Percentage Market Share Breakdown by Volume for Bacterial Sepsis Infection Broad Spectrum Antibiotic Non Responsive, Bacterial Sepsis Infection Broad Spectrum Antibiotic Responsive, Candida Sepsis Infection, and High Risk Un Infected......6
Antivirals......7
Table 5: Antiviral Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......7
Table 6: Therapeutic Classes Market by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Antidiabetics, Antihypertensives, Autoimmune Diseases, HIV Antivirals, Lipid Regulators, Mental Health, Oncologics, Pain, Respiratory Agents, and Others......8
Table 7: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......9
Gram Infection......10
Table 8: Gram Infection Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Other......10
Table 9: Gram Infection Market by Segment in European Union (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Other......11
Table 10: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......12
Table 11: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......13
Gram-Negative Bloodstream Infections Tests......14
Table 12: Gram-Negative Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......14
Gram-Positive Bloodstream Infections Tests......15
Table 13: Gram-Positive Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......15
Urinary Incontinence Drugs......16
Table 14: Urinary Incontinence Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detrol, Detrol LA (PFE), Newer Therapies (ACT, AGN, PFE), Oxybutinin, and Others (Generics)......16
Table 15: Urinary Incontinence Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anticholinergic Agents, and Newer Therapies......17
Urinary Incontinence Therapeutics......18
Table 16: Market Shares of Leading Urinary Incontinence Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Eli Lilly and Company, Johnson & Johnson, Novartis AG, Pfizer, Inc., and Others......18
Antivirals......19
Table 17: Market Shares of Leading Anti-viral Oral Liquids Producers in China (2015) - Percentage Share Breakdown by Value for Livzon Pharmaceutical Group Inc., Xiangxue Pharmaceutical Co., Ltd. and Others......19